¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Genes, Immunoglobulin Light Chain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • reverse transcriptase polymerase chain reaction
    ¿ªÀü»çÈ¿¼ÒÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • straight chain molecule
    °ðÀº»ç½½ºÐÀÚ
  • sympathetic chain
    ±³°¨½Å°æÁÙ±â
  • side chain
    °ç»ç½½
  • side chain isomerism
    ¿·»ç½½À̼º
  • axial light
    Ã౤
  • black light
    Èæ»ö±¤¼±
  • coherent light
    Áý¼ÓÆòÇ౤
  • cone of light
    ±¤Ã߸é
  • consensual light reflex
    °ø°¨ºû¹Ý»ç
  • convergent light
    ¸ðÀÓ±¤¼±, ¼ö·Å±¤¼±
  • divergent light
    ÆÛÁü±¤¼±
  • emergency light reflex
    ÀÀ±Þºû¹Ý»ç
  • fixation light
    Áֽõî
  • incident light
    ÀԻ籤¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • light alloy
    °æÇÕ±Ý
  • black light
    Èæ»ö±¤¼±
  • coherent light
    Áý¼ÓÆòÇ౤
  • consensual light reflex
    ¸Âµ¿°øºû¹Ý»ç, °ø°¨´ë±¤¹Ý»ç
  • convergent light
    ¸ðÀÓ±¤¼±, ¼ö·Å±¤¼±
  • light cell
    ¹àÀº¼¼Æ÷
  • light coagulation
    (¢¡photocoagulation) ±¤ÀÀ°í
  • divergent light
    ÆÛÁü±¤¼±
  • pupillary light-near dissociation
    µ¿°øºû±ÙÁ¢¹Ý»çÇØ¸®
  • light eruption
    ºû¹ßÁø
  • polymorphous light eruption
    ´ÙÇüű¤¼±¹ßÁø, ¿©·¯Çüźû¹ßÁø
  • fixation light
    Áֽõî
  • light fiber
    ¹àÀº±ÙÀ°¼¶À¯, ¹àÀº±ÙÀ°¼¼Æ÷
  • light hydrogen
    °æ¼ö¼Ò
  • incident light
    ÀԻ籤¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Ig A = immunoglobulin A
    ¸é¿ª¸¦·ÎºóA
  • Ig E = immunoglobulin E
    ¸é¿ª±Û·ÎºóE
  • Ig G = immunoglobulin G
    ¸é¿ª±Û·ÎºóG
  • Ig M = immunoglobulin M
    ¸é¿ª±Û·ÎºóM
  • Immunoglobulin G = Ig G
    ¸é¿ª±Û·ÎºÒ¸°G
  • Immunoglobulin M = Ig M
    ¸é¿ª±Û·ÎºÒ¸°M
  • Immunoglobulin adhesion receptors
    ¸é¿ª±Û·ÎºÒ¸° ºÎÂø(ݾó·)¼ö¿ëü
  • Rh immunoglobulin
    Rh ¸é¿ª±Û·ÎºÒ¸°
  • allotype of immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°ÀÌÀÎÀÚÇü<--µ¿Á¾ÀÌÀÎÀÚÇü>
  • amylase complex with immunoglobulin = macroamylase
    ¸é¿ª±ÛºÒ¸°¾Æ¹Ð¶óÁ¦º¹ÇÕü=¸¶Å©·Î¾Æ¹Ð¶óÁ¦
  • framework region in immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°°ñ°ÝºÎ
  • ig => immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°.
  • immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°(Øó湡­)
  • immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • immunoglobulin g(igg)
    ¸é¿ª±Û·ÎºÒ¸° G(Øó湡­)
  • immunoglobulin gene
    ¸é¿ª±Û·ÎºÒ¸°À¯ÀüÀÎÀÚ
  • immunoglobulin m(igm)
    ¸é¿ª±Û·ÎºÒ¸° M(Øó湡­)
  • immunoglobulin production
    ¸é¿ª±Û·ÎºÒ¸°»ý¼º<--»ý»ê>
  • immunoglobulin receptor
    ¸é¿ª±Û·ÎºÒ¸° ¼ö¿ëü
  • immunoglobulin structure
    ¸é¿ª±Û·ÎºÒ¸° ±¸Á¶
  • immunoglobulin subclass
    ¸é¿ª±Û·ÎºÒ¸°¼­ºêŬ·¡½º.
  • immunoglobulin subgroup analysis
    ¸é¿ª±Û·ÎºÒ¸°¾ÆÇüºÐ¼®
  • immunoglobulin supergene family
    ¸é¿ª±Û·ÎºÒ¸° À¯ÀüÀÚÃʰŴëÁý´Ü
  • immunoglobulin, surface
    ¼¼Æ÷Ç¥¸é ¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin-coated erythrocyte
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂøÀûÇ÷±¸
  • isotype of immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°µ¿Á¾Çü
  • monoclonal immunoglobulin
    ´ÜÀÏŬ·Ð¸é¿ª±Û·ÎºÒ¸°
  • monoclonal immunoglobulin detection
    ´ÜÀÏŬ·Ð¸é¿ª±Û·ÎºÒ¸°°ËÃâ
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • B chain
    B »ç½½
  • beta chain
    º£Å¸ »ç½½
  • branched-chain ketoaciduria
    °ç»ç½½ ŰÅä»ê(ß«)´¢Áõ(Òãñø)
  • carbon chain
    ź¼Ò(÷©áÈ) »ç½½
  • C-chain
    C»ç½½
  • chain
    »ç½½
  • chain conformation
    »ç½½ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • chain elongation
    »ç½½¿¬Àå(æÅíþ)
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
  • chain initiation
    »ç½½Çü¼º(û¡à÷)°³½Ã(ËÒã·)
  • chain isomer
    »ç½½À̼ºÃ¼(ì¶àõô÷)
  • chain length
    »ç½½ ±æÀÌ
  • chain propagation
    »ç½½ Áõ½Ä(ñòãÖ)
  • chain reaction
    ¿¬¼â¹ÝÀÀ(ææáðÚãëë)
  • chain termination
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MLC minimum lethal concentration; mixed leukocyte culture; mixed ligand chelate; mixed lymphocyte concen...
MLCK myosin light chain kinase
MLCP myosin light-chain phosphatase
MYL light chain myosin
PKCSL protein kinase C light chain
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MRLC Myosin regulatory light chain
R-LC Regulatory light chain
RMLC Regulatory myosin light chain
smMLCK Smooth muscle myosin light chain kinase
AL amyloid light chain
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • light brown pigmentation
    ¿¬°¥»ö »ö¼Ò Ä§Âø
  • light cured
    ±¤ ÁßÇÕ
    ºûÀÇ Á¶»ç¿¡ ÀÇÇØ¼­ ÀϾ´Â ÁßÇÕ ¹ÝÀÀ. ¼ø¼ö ±¤ ÁßÇÕ°ú ±¤ Áõ°¨ ÁßÇÕÀ¸·Î ³ª´©´Âµ¥, ¾î´À °ÍÀ̳ª Àڿܼ± ¶Ç´Â °¡½Ã±¤¼±ÀÌ »ç¿ëµÈ´Ù. °íºÐÀÚ È­ÇÕ¹° ±¸Á¶¿¡¼­ ¹Ýº¹´ÜÀ§ÀÇ ±âÃʰ¡ µÇ´Â ºñ±³Àû ºÐÀÚ·®ÀÌ ÀÛÀº È­ÇÕ¹°
  • light curing composite resin
    ±¤ ÁßÇÕÇü º¹ÇÕ ·¹Áø
  • light difference
    ±¤Â÷
    ±¤¼±¿¡ ´ëÇÑ µÎ ´«ÀÇ °¨¼ö¼ºÀÇ Â÷ÀÌ. L.D.À¸·Î Á¾Á¾ Ç¥±âÇÑ´Ù.
  • light fluence
    ±¤ ¿¡³ÊÁö ¹Ðµµ
  • light microscope
    ±¤ÇÐÇö¹Ì°æ
    Ç¥º»À» ºûÀÇ ¹Ý»ç, ±¼Àý µîÀÇ ¼ºÁúÀ» ÀÌ¿ëÇØ¼­ °üÂûÇÏ´Â Çö¹Ì°æ.
  • light minimum
    ÃÖ¼Ò¼ö ±¤·®
    ´«À¸·Î °¨ÁöµÇ´Â ÃÖ¼Ò·®ÀÇ ±¤¼±À¸·Î¼­ L.M.À¸·Î Ç¥±âÇÑ´Ù.
  • light propagation
    ±¤ Àüµµ
    ¹ÝµµÃ¼¿¡ ºûÀ» Á¶»çÇϸé Àü±â Àüµµµµ°¡ ±ÞÁõÇÏ¿© Àü·ù°¡ È帣±â ½¬¿öÁö´Â Çö»ó. ³»ºÎ ±¤Àü È¿°ú¶ó°íµµ ÇÑ´Ù. Ȳȭ ³³ , Ȳȭ Ä«µå¹Å µîÀÇ ¹ÝµµÃ¼´Â ±¤Àüµµ È¿°ú°¡ ÁÁÀ¸¹Ç·Î ±¤Àüµµ ¼¿À» ¸¸µé¾î ºûÀÇ ¼¼±â ÃøÁ¤ ÀåÄ¡, ƯÈ÷ Ä«¸Þ¶óÀÇ ³ëÃâ°è µîÀ¸·Î ¸¹ÀÌ ¾²ÀδÙ. ¼¿·»À̳ª Ȳȭ Ä«µå¹Å µîÀÇ ¹ÝµµÃ¼¿¡ ºûÀ» Á¶»çÇÏ¸é ¿øÀÚ°¡ ÀüÀÚ ¶ìÀÇ ÀüÀÚ°¡ ºûÀ» Èí¼öÇÏ¿© Àüµµ ¶ì·Î ¿Å¾Æ°¡ ¾ç°øÀÌ »ý±ä´Ù. À̵éÀÌ Àü·ùÀÇ ¿î¹Ýü
  • light red
    ¿¬È«»ö
  • light reflex
    ´ë±¤ ¹Ý»ç, ´ë±¤ ¹ÝÀÀ, ±¤ ¹Ý»ç, ±¤¼± ¹Ý»ç, ºû ¹Ý»ç
    1. °í¸·¿¡¼­ ¹Ý»çÇÏ´Â ±¤»ó. 2. ¸Á¸·°æÀÇ °Å¿ï·Î ¸Á¸·¿¡¼­ ¹Ý»çµÇ¾î º¸À̴ ȯ»ó ±¤Á¡. 3. ´«¿¡ ºûÀ» ºñÃß¸é µ¿°øÀÌ Ãà¼ÒµÇ´Â °Í.
  • light scattering
    ±¤ »ê¶õ
    ÆÄµ¿À̳ª °í¼ÓµµÀÇ ÀÔÀÚ¼±ÀÌ ¸¹Àº ºÐÀÚ, ¿øÀÚ, ¹Ì¸³ÀÚ µî¿¡ Ãæµ¹ÇÏ¿© ¿îµ¿ ¹æÇâÀ» ¹Ù²Ù°í Èð¾îÁö´Â ÀÏ. »ê¶õµÈ ÆÄµ¿À» »ê¶õÆÄ¶ó ÇÑ´Ù. ºûÀÎ °æ¿ì¿¡´Â »ê±¤À̶ó Çϸç, ÀÌ·ÐÀûÀ¸·Î´Â ¿øÀÚ³ª ºÐÀÚ¿¡ ¼Ó¹ÚµÇ¾î ÀÖ´Â ÀüÀÚ°¡ ÀÔ»ç ±¤¼±ÀÇ ÀüÀÚ±âÆÄ¿¡ ÀÇÇÏ¿© °­Á¦ Áøµ¿À» ÀÏÀ¸ÄÑ 2Â÷Àû ºûÀ» ³»´Â Çö»óÀ̸ç, ´ÜÆÄÀåÀÇ ºûÀϼö·Ï °­ÇÏ°Ô »ê¶õµÈ´Ù. ·¹Àϸ®´Â ÆÄÀå¿¡ ºñÇÏ¿© ÀÛÀº ¹Ì¸³ÀÚ¿¡ ÀÇÇÑ Çö»óÀ» ¿¬±¸ÇÏ¿© »ê±¤ÀÇ ¼¼±â°¡ ÆÄÀåÀÇ 4Á¦°ö¿¡ ¹Ýºñ·ÊÇÑ´Ù´Â °ÍÀ» ¹ß°ßÇϰí, û»ö ºûÀº ´ë±â ÁßÀÇ ºÐÀÚ³ª ¹Ì¸³ÀÚ¿¡ ÀÇÇÏ¿© ÅÂ¾ç ±¤¼±ÀÌ »ê¶õµÈ °ÍÀ̶ó°í ÇÏ¿´´Ù. ¸¶Âù°¡Áö·Î žçÀ̳ª ´ÞÀÌ ¶ã ¶§
  • light sense
    ½Ã°¢
    ºûÀÇ °¨°¢ ¹× ±×¿¡ µû¸£´Â °ø°£ÀÇ °¨°¢. À̰ÍÀ¸·Î ¿ì¸®´Â ¿Ü°èÀÇ ¹°Ã¼ÀÇ Å©±â, ÇüÅÂ, ºû, ¹à±â µîÀ» ºñ·ÔÇÏ¿© °ø°£¿¡ À־ÀÇ À§Ä¡¿Í ¿îµ¿À» ¾Ë ¼ö ÀÖ´Ù. ½Ã°¢ ±â°üÀº ´«ÀÌÁö¸¸, ºûÀ» ´À³¢´Â °÷Àº ´« ¾ÈÀÇ ¸Á¸·»ÓÀ̸ç, ±× ¹ÛÀÇ ±¸Á¶´Â ºûÀ» ¹Ù¸£°Ô ¸Á¸·À¸·Î µµ´Þ½ÃŰ°Ô Çϱâ À§ÇÑ Å뱤 ÀåÄ¡¿¡ Áö³ªÁö ¾Ê´Â´Ù. ºûÀ» ±¼Àý½ÃŰ´Â °ÍÀº °¢¸·, ¾È ¹æ¼ö, ¼öÁ¤Ã¼, À¯¸®Ã¼ µîÀε¥ ±× Áß¿¡¼­ ¼öÁ¤Ã¼ÀÇ ±¼Àý·üÀÌ °¡Àå Å©¹Ç·Î, ´«¿¡¼­ÀÇ ºûÀÇ ±¼ÀýÀº ÁÖ·Î ¼öÁ¤Ã¼°¡ ¸Ã°í ÀÖ´Ù. Á¤»óÀûÀÎ »ç¶÷ÀÇ ´«Àº ´«¾Õ ¾à 6 m ÀÌ»óÀÇ °Å¸®¿¡ ÀÖ´Â ¹°Ã¼¸¦ ¸Á¸·¿¡ Á¤È®ÇÏ°Ô »óÀ» ¸ÎÁö¸¸ À̺¸´Ù °¡±îÀÌ ÀÖÀ¸¸é ¸Á¸· ÈĹ濡¼­ »óÀ» ¸Î°Ô µÇ¹Ç·Î, ¼öÁ¤Ã¼¸¦ µÎ²®°Ô ÇØ¼­ ±¼Àý·üÀ» Áõ´ë½ÃŲ´Ù. À̰ÍÀ» ´«ÀÇ Á¶ÀýÀÛ¿ëÀ̶ó ÇÏ¸ç ³ªÀ̰¡ ¸Ô¾î°¥¼ö·Ï °¨ÅðµÈ´Ù. ¸Á¸·Àº ´«ÀÇ ³»¸éÀ» µ¤°í ÀÖ´Â ¸·À¸·Î ¸î °³ÀÇ ¼¼Æ÷°¡ ÃþÀ» ÀÌ·ç°í ÀÖÀ¸³ª, ºûÀ» ´À³¢´Â °ÍÀº °¡Àå ¹Ù±ùÂÊ¿¡ ÀÖ´Â ½Ã ¼¼Æ÷ÀÌ´Ù. ½Ã ¼¼Æ÷´Â ±× µ¹±âÀÇ ¸ð¾ç¿¡ µû¶ó ¿øÃß ¼¼Æ÷¿Í °£»ó ¼¼Æ÷ÀÇ µÎ Á¾·ù·Î ±¸º°ÇÑ´Ù. ¿øÃß ¼¼Æ÷´Â ¸Á¸· Á߽ɺο¡ ¸¹°í, ºûÀÌ °­ÇÑ ¶§ ÀÛ¿ëÇÏ¸ç ºû±òÀ» ´À³¢´Â ±â´ÉÀÌ ÀÖ´Ù. °£»ó ¼¼Æ÷´Â ¸Á¸· ÁÖº¯ºÎ¿¡ ¸¹ÀÌ ºÐÆ÷ÇÏ°í ¾îµÎ¿î °÷¿¡¼­ ¾àÇÑ ¸í¾ÏÀÇ Â÷¸¦ ´À³¤´Ù. ½Ã ¼¼Æ÷´Â ¾ç±Ø ¼¼Æ÷¸¦ ÅëÇÏ¿© ½Å°æ ¼¼Æ÷¿¡ ¿¬°áµÇ¾î ÀÖÀ¸³ª, ¿øÃß ¼¼Æ÷´Â ÇϳªÀÇ ¼¼Æ÷°¡ ÇϳªÀÇ ½Å°æ ¼¼Æ÷¿Í ´ëÀÀÇϰí ÀÖÀ¸¹Ç·Î ¹°Ã¼¸¦ ¸íÈ®ÇÏ°Ô ±¸º°ÇÏ´Â µ¥ Àû´çÇÏ´Ù. °£»ó ¼¼Æ÷´Â ¿©·¯ °³ÀÇ ¼¼Æ÷°¡ ÇϳªÀÇ ½Å°æ ¼¼Æ÷¿Í ¿¬°áµÇ¾î ÀÖ´Ù. ½Å°æ ¼¼Æ÷ÀÇ µ¹±â´Â ½Ã¼Ó ½Å°æÀÌ µÇ¾î ´«¿¡¼­ ³ª¿À¸é ±³Â÷ÇÏ¿© ¿ÜÃø ½½»óü¿¡¼­ ³¡³­´Ù. ÀÌ ¶§ µÎ ´«ÀÇ ¿ÞÂÊ ¹ÝÀÌ ÁÂÃø ½½»óü·Î °¡°í, ¿À¸¥ÂÊ ¹ÝÀÌ ¿ìÃøÀ¸·Î °£´Ù. ¿ÜÃø ½½»óü¿¡¼­ ½Ã¹æ¼±À» °ÅÃÄ °°Àº ÂÊÀÇ Èĵο±ÀÇ ½Ã°¢·É¿¡ À̸¥´Ù. ºûÀÇ °¨°¢¿¡´Â ºûÀÇ ¾çÀÇ ´Ù¼Ò¸¦ ±¸º°ÇÏ´Â ¹à±âÀÇ °¨°¢°ú, ºûÀÇ Á¾·ù¸¦ ±¸º°ÇÏ´Â »öÀÇ °¨°¢ÀÌ ÀÖ´Ù. ¹à±âÀÇ °¨°¢Àº ¿Ü°èÀÇ »óȲ¿¡ µû¶ó ´Þ¶óÁö¸ç ¾îµÎ¿î °÷¿¡ ÀÖÀ¸¸é Á¡Â÷ ¸Á¸·ÀÇ °¨¼ö¼ºÀÌ ³ô¾ÆÁö°í, ¹àÀº °÷À¸·Î ³ª¿À¸é À绡¸® ¸Á¸·ÀÇ °¨¼ö¼ºÀÌ ³·¾ÆÁø´Ù. ¶Ç, ºûÀÌ µé¾î¿Íµµ ÀÏÁ¤ ½Ã°£ÀÌ °æ°úÇÏÁö ¾ÊÀ¸¸é ±× ºû¿¡ ´ëÀÀÇÏ´Â ´À³¦ÀÌ ÀϾÁö ¾ÊÀ¸¸ç, ¹Ý´ë·Î ºûÀ» Â÷´ÜÇØµµ °¨°¢Àº ±Ý¹æ ¾ø¾îÁöÁö ¾Ê°í Àá½Ã ³²´Â´Ù. ºñ°¡ ½Ç°°ÀÌ º¸ÀÌ´Â °ÍÀº ÀÌ ¶§¹®ÀÌ´Ù. »öÀÇ °¨°¢Àº ÁÖ·Î ÆÄÀå¿¡ °ü°èµÈ´Ù. »ç¶÷ÀÌ ´À³¥ ¼ö ÀÖ´Â ºûÀº ÆÄÀåÀÌ 760¡­380 nm ±îÁö À̰í, ½ºÆåÆ®·³À¸·Î ±¸º°ÇÒ ¼ö ÀÖ´Â »ö»óÀº »¡°­¿¡¼­ º¸¶ó»ö±îÁöÀε¥, »ç¶÷ÀÇ ´«Àº ¾à 160°¡ÁöÀÇ »ö»óÀ» ±¸º°ÇÒ ¼ö ÀÖ´Ù. »ö»óÀ» ½Äº°ÇÏ´Â µ¥ ÇÊ¿äÇÑ ºûÀÇ °­µµ´Â »ö¿¡ µû¶ó ´Ù¸£¸ç, ÃæºÐÈ÷ ¹àÀº ¶§´Â ³ë¶õ»öÀÌ ¹à°í, ÀÚÁÖ»öÀº ¾îµÓ°Ô º¸ÀδÙ. ±×·¯³ª ºûÀÌ ¾àÇØÁö¸é ½ºÆåÆ®·³¿¡¼­ °¡Àå ¹à°Ô º¸ÀÌ´Â ºÎºÐÀÌ ³ë¶û¿¡¼­ ³ì»ö ÂÊÀ¸·Î ¿Å°Ü°¡¹Ç·Î ÇØÁú ¹«·Æ¿¡´Â ÆÄ¶õ»öÀÌ Àß º¸ÀδÙ. ¹à±â³ª »ö °¨°¢ À̿ܿ¡, ¿Ü°èÀÇ ¹°Ã¼ÀÇ ¸ð¾ç, À§Ä¡, °Å¸® µîÀ» ¾Ë¾Æ³»´Â °ø°£ °¨°¢ÀÌ ÀÖ´Ù. ¶È¹Ù·Î Àü¹æÀ» º¸°í ´«¿¡ º¸ÀÌ´Â ¹üÀ§¸¦ ½Ã¾ß¶ó°í ÇÏ¸ç ¿ÜÇϹæÀÌ °¡Àå ³Ð°í, ±× ¹ÛÀÇ ¹æÇâÀ¸·Î´Â Á¼´Ù. ¶Ç, ¹°Ã¼ÀÇ ¸ð¾çÀ» ºÐ°£ÇÏ´Â ´É·ÂÀ» ½Ã·ÂÀ̶ó Çϸç, ¹°Ã¼¸¦ µÑ·Î ±¸º°ÇÏ´Â ÃÖ¼ÒÀÇ ½Ã°¢À¸·Î Ç¥½ÃÇÏ´Â µ¥ Æò±Õ 1ºÐÀ̸ç ÀÌ ¿ª¼ö¸¦ ½Ã·ÂÀ̶ó°í ÇÑ´Ù. ÇÑÂÊ ´«À¸·Îµµ ¹°Ã¼ÀÇ ¸ð¾çÀ» ºÐ°£ÇÒ ¼ö´Â ÀÖÀ¸³ª, µÎ ´«À¸·Î º¸¸é ¾çÂÊ ½Ã¾ß°¡ °ãÃļ­ ³ÐÀº ¹üÀ§°¡ º¸À̰í, µ¿½Ã¿¡ µÎ ´«À¸·Î ÇÔ²² º¸ÀÌ´Â ºÎºÐ¿¡¼­´Â ½Ã·ÂÀÌ Áõ°¡µÇ¸ç, ¶Ç ±íÀÌ¿¡ ´ëÇÑ °¨°¢µµ »ý±ä´Ù.¡¼µ¿¹°¡½ ¿Ü°è·ÎºÎÅÍ ¹Þ´Â ÀÚ±Ø Áß¿¡¼­ ºûÀ» ÀûÇÕ ÀÚ±Ø
  • light source
    ±¤¿ø
    Àü±¸, ¾çÃÊ, ÅÂ¾ç µî ºûÀ» ³»´Â ¹°Ã¼ ¶Ç´Â ÀåÄ¡. Àΰø ±¤¿øÀ¸·Î¼­ ÀüµîÀÌ ¹ß¸íµÉ ¶§±îÁö´Â ¼®À¯µî, °¡½ºµî µîÀÌ ¾²¿´´Âµ¥, ÀüµîÀÌ ³ª¿Â µÚºÎÅÍ´Â °ÅÀÇ À̰ÍÀ¸·Î ´ëüµÇ¾ú´Ù. °¡Àå ÁÁÀº Àΰø ±¤¿øÀ¸·Î¼­´Â ÅÂ¾ç ±¤¿¡ °¡±î¿î »öÀ» ³»°í °ªÀÌ ½Î¸ç ¼ö¸íÀÌ ±ä ¹é¿­ Àü±¸°¡ ¾²¿´°í, ±× µÚ Çü±¤µîÀÌ ³Î¸® ¾²ÀÌ°Ô µÇ¾ú´Ù. ±× ¹Û¿¡ ¼öÀºµî, ³ªÆ®·ý ·¥ÇÁ µîµµ ¿Á¿Ü¿ë ±¤¿øÀ¸·Î¼­ ¿ëµµ°¡ È®´ëµÇ°í ÀÖ´Ù. ±¤¿øÀÇ °¡Àå ±âº»ÀûÀÎ ÇüÅ´ ũ±â°¡ ¹«½ÃµÇ´Â Á¡±¤¿øÀÌ´Ù. Àü±¸³ª ž絵 Á¡±¤¿øÀ¸·Î º¼ ¼ö ÀÖ´Ù. Á¡±¤¿øÀ¸·ÎºÎÅÍ ¾î¶² ¸éÀÌ Á¶¸íµÇ°í ÀÖÀ» ¶§, ±× ¸éÀÇ ¹à±â´Â ±¤¿ø¿¡¼­ ¸é±îÁöÀÇ °Å¸®ÀÇ Á¦°ö¿¡ ¹Ýºñ·ÊÇÑ´Ù. ±¤¿øÀÇ ¹à±â´Â ±¤¼ÓÀÇ ´ÜÀ§ÀÎ ·ç¸à
  • light spot
    ¹é»ö ¹ÝÁ¡
  • light therapy
    ±¤¼± Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
intravenous immunoglobulin <pharmacology> A sterile solution of concentrated antibodies extracted from healthy people. IVIG is used to prevent bacterial infections in people with low or inappropriate antibody production. Injected into a vein or muscle.
(09 Oct 1997)
tetanus immunoglobulin <protein> A protein antibody to tetanus toxin, given as passive immunity for those lacking any prior tetanus vaccination.
(27 Sep 1997)
thyroid stimulating immunoglobulin <protein> A test that measures the amount of an antibody (thyroid stimulating antibody) which is directed against a receptor for TSH on the thyroid gland. This antibody acts like TSH and stimulates the thyroid to produce excessive amounts of thyroid hormone. The presence of this antibody generally indicates Grave's disease (hyperthyroidism).
(27 Sep 1997)
alternating light test Test to detect a relative afferent defect in one eye by watching pupillary movements.
With the patient fixing in the distance, the light is held on each eye for about a second, and quickly moved to the other eye. Assuming no defect of the innervation to the iris sphincter in one eye (which would produce an anisocoria in light), the eye with the weaker light response has a relative afferent pupillary defect.
This asymmetry of pupillomotor input can be estimated by holding neutral density filters in front of the better eye until the pupillary responses of the two eyes are balanced.
Synonym: swinging light test.
(05 Mar 2000)
Begg light wire differential force technique An orthodontic appliance utilizing small gauge labial wires with expansion and contraction loops formed into it and attached to bands fitted to individual teeth; sometimes called Begg light wire differential force technique.
(05 Mar 2000)
ray, light <microscopy> The term applied to the lines perpendicular to the wavefronts of waves of light to indicate their direction of travel in an isotropic medium.
Note the wave normal and the ray do not coincide in isotropic media.
(05 Aug 1998)
reflected light Light directed backward from a mirror.
(05 Mar 2000)
refracted light Bent rays of light changed in passage from one transparent medium to another of unequal density.
See: refraction.
(05 Mar 2000)
visible light <physics> Electromagnetic radiation with wavelengths between 400 nanometres and 750 nanometres. Electromagnetic radiation within this range can be detected by the human eye. Colours depend on the wavelength lengths, a short wavelength (the 400 nm side) looks blue and a long wavelength (the 750 nm side) looks red.
(09 Oct 1997)
metals, light Metals with low specific gravity, typically smaller than 5, characterised by a single valence (1, 2, or 3), a simple spectrum, strong electromotive force (positive), and colourless compounds.
(12 Dec 1998)
minimum light Threshold of visual sensation, the minimal light intensity evoking a visual sensation.
Synonym: achromatic threshold, minimum light threshold.
(05 Mar 2000)
minimum light threshold Threshold of visual sensation, the minimal light intensity evoking a visual sensation.
Synonym: achromatic threshold, minimum light threshold.
(05 Mar 2000)
cold light Fluorescent light as opposed to incandescent light.
(05 Mar 2000)
monochromatic light <microscopy> Light composed of one wavelength. It may be obtained by the use of a laser or by gaseous discharge tubes in combination with proper filters. An approximation is obtained by interference filters or monochromators.
(05 Aug 1998)
plane-polarized light <chemistry> Light which is passed through a filter which blocks out all the light except that which ocillates in one plane.
(09 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mountain chain
    »ê¸Æ
  • watch chain
    ȸÁß ½Ã°èÀÇ ¼èÁÙ
  • in the light of
    -¿¡ ºñÃß¾î º¼ ¶§
  • light
    ºû,¹àÀº,°¡º­¿î,Á¡È­ÇÏ´Ù,°¡º±°Ô
  • light-handed
    ¼Ø¾¾°¡ ÁÁÀº
  • light-headed
    ¸ù·ÕÇÑ
  • light-heartedness
    ³«ÃµÀûÀÓ
  • light-minded
    °æ¼ÖÇÑ
  • make light of
    °æ½ÃÇÏ´Ù
  • shed light on
    ÀÇ ¼³¸í¿¡ µµ¿òÀ» ÁÖ´Ù
  • throw light on
    ¿¡ ÇØ°áÀÇ ±¤¸íÀ» ÁÖ´Ù
  • Finsen light
    Çɼ¾±¤(·¥ÇÁ)
  • Inner Light
    ³»ÀûÀÎ ºû(ÄùÀÌÄ¿ ±³µµ°¡ ¸¶À½ ¼Ó¿¡ ´À³¢´Â ±×¸®½ºµµÀÇ ºû ?,
  • calcium light
    Ä®½·±¤(limelight)
  • ceiling light
    »ï°¢Ãø·®À¸·Î ¿îÀú °íµµ¸¦ Àç´Â ŽÁ¶µî
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á